Utility of Monitoring H3.1 Plasma Concentrations as a Surrogate of Treatment Response and Remission in Dogs with Cancer

Poster titled: ‘Utility of Monitoring H3.1 Plasma Concentrations as a Surrogate of Treatment Response and Remission in Dogs with Cancer’.

Presented at: World Veterinary Cancer Congress 2024, Tokyo 2024

Dr Heather Wilson-Robles et al